These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16055199)

  • 1. The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.
    Neale JH; Olszewski RT; Gehl LM; Wroblewska B; Bzdega T
    Trends Pharmacol Sci; 2005 Sep; 26(9):477-84. PubMed ID: 16055199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of N-acetylaspartylglutamate peptidases: a novel protective strategy for brain injuries and neurological disorders.
    Zhong C; Luo Q; Jiang J
    Int J Neurosci; 2014 Dec; 124(12):867-73. PubMed ID: 24494725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.
    Zuo D; Bzdega T; Olszewski RT; Moffett JR; Neale JH
    J Biol Chem; 2012 Jun; 287(26):21773-82. PubMed ID: 22570482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.
    Neale JH; Olszewski RT; Zuo D; Janczura KJ; Profaci CP; Lavin KM; Madore JC; Bzdega T
    J Neurochem; 2011 Aug; 118(4):490-8. PubMed ID: 21644997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model.
    Yamamoto T; Hirasawa S; Wroblewska B; Grajkowska E; Zhou J; Kozikowski A; Wroblewski J; Neale JH
    Eur J Neurosci; 2004 Jul; 20(2):483-94. PubMed ID: 15233757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors.
    Olszewski RT; Wegorzewska MM; Monteiro AC; Krolikowski KA; Zhou J; Kozikowski AP; Long K; Mastropaolo J; Deutsch SI; Neale JH
    Biol Psychiatry; 2008 Jan; 63(1):86-91. PubMed ID: 17597589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target.
    Baslow MH
    Drug News Perspect; 2008 Jun; 21(5):251-7. PubMed ID: 18596989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracerebroventricular administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in inflammatory pain.
    Yamamoto T; Kozikowski A; Zhou J; Neale JH
    Mol Pain; 2008 Aug; 4():31. PubMed ID: 18673570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetylaspartylglutamate (NAAG) and glutamate carboxypeptidase II: An abundant peptide neurotransmitter-enzyme system with multiple clinical applications.
    Neale JH; Yamamoto T
    Prog Neurobiol; 2020 Jan; 184():101722. PubMed ID: 31730793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.
    Olszewski RT; Bukhari N; Zhou J; Kozikowski AP; Wroblewski JT; Shamimi-Noori S; Wroblewska B; Bzdega T; Vicini S; Barton FB; Neale JH
    J Neurochem; 2004 May; 89(4):876-85. PubMed ID: 15140187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat.
    Zhong C; Zhao X; Van KC; Bzdega T; Smyth A; Zhou J; Kozikowski AP; Jiang J; O'Connor WT; Berman RF; Neale JH; Lyeth BG
    J Neurochem; 2006 May; 97(4):1015-25. PubMed ID: 16606367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
    Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH
    Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAAG, NMDA receptor and psychosis.
    Bergeron R; Coyle JT
    Curr Med Chem; 2012; 19(9):1360-4. PubMed ID: 22304714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.
    Profaci CP; Krolikowski KA; Olszewski RT; Neale JH
    Psychopharmacology (Berl); 2011 Jul; 216(2):235-43. PubMed ID: 21327758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for N-acetylaspartylglutamate (NAAG) and mGluR3 in cognition.
    Neale JH; Olszewski R
    Neurobiol Learn Mem; 2019 Feb; 158():9-13. PubMed ID: 30630041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for the locus coeruleus in the analgesic efficacy of N-acetylaspartylglutamate peptidase (GCPII) inhibitors ZJ43 and 2-PMPA.
    Nonaka T; Yamada T; Ishimura T; Zuo D; Moffett JR; Neale JH; Yamamoto T
    Mol Pain; 2017 Jan; 13():1744806917697008. PubMed ID: 28326936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistological and electrophysiological evidence that N-acetylaspartylglutamate is a co-transmitter at the vertebrate neuromuscular junction.
    Walder KK; Ryan SB; Bzdega T; Olszewski RT; Neale JH; Lindgren CA
    Eur J Neurosci; 2013 Jan; 37(1):118-29. PubMed ID: 23134476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NAAG peptidase inhibitors and their potential for diagnosis and therapy.
    Zhou J; Neale JH; Pomper MG; Kozikowski AP
    Nat Rev Drug Discov; 2005 Dec; 4(12):1015-26. PubMed ID: 16341066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Acetylaspartylglutamate: the most abundant peptide neurotransmitter in the mammalian central nervous system.
    Neale JH; Bzdega T; Wroblewska B
    J Neurochem; 2000 Aug; 75(2):443-52. PubMed ID: 10899918
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.